Dramatic Response to Combination Erlotinib and Crizotinib in a Patient with Advanced, EGFR-Mutant Lung Cancer Harboring De Novo MET Amplification

Saved in:
Bibliographic Details
Published in:Journal of thoracic oncology 2016-07, Vol.11 (7), p.e83-e85
Main Authors: Gainor, Justin F., Niederst, Matthew J., Lennerz, Jochen K., Dagogo-Jack, Ibiayi, Stevens, Sara, Shaw, Alice T., Sequist, Lecia V., Engelman, Jeffrey A.
Format: Article
Language:English
Subjects:
Aged
Antineoplastic Combined Chemotherapy Protocols - therapeutic use
Erlotinib Hydrochloride - administration & dosage
Female
Gene Amplification
Humans
Lung Neoplasms - drug therapy
Lung Neoplasms - genetics
Lung Neoplasms - pathology
Mutation
Prognosis
Proto-Oncogene Proteins c-met - genetics
Pyrazoles - administration & dosage
Pyridines - administration & dosage
Receptor, Epidermal Growth Factor - genetics
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:
ISSN:1556-0864
1556-1380
DOI:10.1016/j.jtho.2016.02.021